Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 105 OTHER 90 UNKNOWN 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 213 Carcinoma, Non-Small-Cell Lung 148 Lung Neoplasms 128 Lymphoma 119 Prostatic Neoplasms 115 Leukemia 102 Ovarian Neoplasms 100 Central Nervous System Neoplasms 95 Precursor Cell Lymphoblastic Leukemia-Lymphoma 89 Colorectal Neoplasms 89 Head and Neck Neoplasms 87 Sarcoma 84 Multiple Myeloma 80 Squamous Cell Carcinoma of Head and Neck 73 Rectal Neoplasms 62 Leukemia, Myeloid, Acute 62 Carcinoma, Ovarian Epithelial 61 Uterine Cervical Neoplasms 60 Neoplasm Metastasis 59 Brain Neoplasms 57 Colonic Neoplasms 56 Fallopian Tube Neoplasms 53 Astrocytoma 53 Lymphoma, Large B-Cell, Diffuse 50 Glioblastoma 49 Burkitt Lymphoma 47 Urinary Bladder Neoplasms 46 Melanoma 45 Neuroblastoma 44 Hodgkin Disease 44

Interventions

Trastuzumab 1 IFL protocol 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Interventional × Advanced Cancer × Clear all

NCT05605509 2026-02-06

RP-6306 in Patients With Advanced Cancer

Canadian Cancer Trials Group

Phase 2 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡